# AbbVie Inc.: filings

ABBV · NYSE · CIK 1551152 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abbv.md) · [Financials](/companies/abbv/financials.md) · [Filings](/companies/abbv/filings.md) · [Insiders](/companies/abbv/insiders.md)

## Reports and events: 276 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 818, 8-K 198, 425 52, 3 43, 144 42, 10-Q 41, SC 13G/A 31, PX14A6G 22, CORRESP 19, UPLOAD 19, 11-K 16, 424B5 15, S-8 15, 10-K 14, DEF 14A 14, SD 13, DEFA14A 11, PRE 14A 11, 4/A 10, FWP 10, SC TO-T/A 10, SC TO-I/A 9, ARS 7, 10-12B/A 6, 424B3 6, S-3ASR 6, 25-NSE 5, 8-K/A 5, NO ACT 5, SC 13G 5, EFFECT 4, 3/A 3, 8-A12B 3, S-4 3, CERT 2, CERTNYS 2, S-4/A 2, SCHEDULE 13G 2, SCHEDULE 13G/A 2, SC TO-C 2, 10-12B 1, 10-K/A 1, 144/A 1, CT ORDER 1, D 1, S-1 1, S-1/A 1, S-8 POS 1, SC 13D 1, SC TO-I 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 07:51 ET | [8-K](/filings/0001551152-26-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000033 |
| 2026-10-15 | 16:00 ET | [8-K](/filings/0001104659-26-116227.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-116227 |
| 2026-10-05 | 16:07 ET | [8-K](/filings/0001551152-26-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000030 |
| 2026-09-03 | 08:47 ET | [8-K](/filings/0001104659-26-104940.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-104940 |
| 2026-08-18 | 16:30 ET | [8-K](/filings/0001104659-26-098367.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-098367 |
| 2026-08-05 | 17:17 ET | [8-K](/filings/0001104659-26-091269.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-091269 |
| 2026-08-03 | 14:14 ET | [10-Q](/filings/0001551152-26-000026.md) | Quarterly report, period 2026-06-30 | 0001551152-26-000026 |
| 2026-07-31 | 07:51 ET | [8-K](/filings/0001551152-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000023 |
| 2026-07-06 | 16:12 ET | [8-K](/filings/0001551152-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000021 |
| 2026-06-22 | 07:11 ET | [8-K](/filings/0001104659-26-076067.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-076067 |
| 2026-05-12 | 17:01 ET | [8-K](/filings/0001104659-26-059484.md) | 5.07 Shareholder vote results | 0001104659-26-059484 |
| 2026-05-08 | 12:28 ET | [10-Q](/filings/0001551152-26-000017.md) | Quarterly report, period 2026-03-31 | 0001551152-26-000017 |
| 2026-04-29 | 07:50 ET | [8-K](/filings/0001551152-26-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000013 |
| 2026-04-03 | 16:05 ET | [8-K](/filings/0001551152-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000011 |
| 2026-03-23 | 16:59 ET | [DEF 14A](/filings/0001104659-26-033387.md) | Proxy statement, period 2026-05-08 | 0001104659-26-033387 |
| 2026-03-04 | 16:59 ET | [8-K](/filings/0001104659-26-023534.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-023534 |
| 2026-02-26 | 17:14 ET | [8-K](/filings/0001104659-26-020643.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-020643 |
| 2026-02-20 | 14:38 ET | [10-K](/filings/0001551152-26-000008.md) | Annual report, period 2025-12-31 | 0001551152-26-000008 |
| 2026-02-04 | 07:54 ET | [8-K](/filings/0001551152-26-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000004 |
| 2026-01-07 | 16:08 ET | [8-K](/filings/0001551152-26-000002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000002 |
| 2025-11-04 | 14:05 ET | [10-Q](/filings/0001551152-25-000049.md) | Quarterly report, period 2025-09-30 | 0001551152-25-000049 |
| 2025-10-31 | 07:51 ET | [8-K](/filings/0001551152-25-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000047 |
| 2025-10-03 | 16:09 ET | [8-K](/filings/0001551152-25-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000043 |
| 2025-09-11 | 07:30 ET | [8-K](/filings/0001104659-25-089245.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-089245 |
| 2025-08-04 | 15:17 ET | [10-Q](/filings/0001551152-25-000040.md) | Quarterly report, period 2025-06-30 | 0001551152-25-000040 |
| 2025-07-31 | 07:48 ET | [8-K](/filings/0001551152-25-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000036 |
| 2025-07-03 | 13:07 ET | [8-K](/filings/0001551152-25-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000034 |
| 2025-05-13 | 17:58 ET | [8-K](/filings/0001104659-25-047402.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-25-047402 |
| 2025-05-09 | 13:24 ET | [10-Q](/filings/0001551152-25-000029.md) | Quarterly report, period 2025-03-31 | 0001551152-25-000029 |
| 2025-04-25 | 07:48 ET | [8-K](/filings/0001551152-25-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000026 |
| 2025-04-03 | 16:13 ET | [8-K](/filings/0001551152-25-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000023 |
| 2025-03-24 | 16:28 ET | [DEF 14A](/filings/0001558370-25-003537.md) | Proxy statement, period 2025-05-09 | 0001558370-25-003537 |
| 2025-02-26 | 17:04 ET | [8-K](/filings/0001104659-25-017490.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-017490 |
| 2025-02-19 | 09:22 ET | [8-K](/filings/0001104659-25-015015.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-015015 |
| 2025-02-14 | 13:17 ET | [10-K](/filings/0001551152-25-000020.md) | Annual report, period 2024-12-31 | 0001551152-25-000020 |
| 2025-02-14 | 07:30 ET | [8-K](/filings/0001104659-25-013467.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-013467 |
| 2025-02-05 | 16:15 ET | [8-K](/filings/0001104659-25-009673.md) | 8.01 Other events | 0001104659-25-009673 |
| 2025-01-31 | 07:42 ET | [8-K](/filings/0001551152-25-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000011 |
| 2025-01-10 | 08:31 ET | [8-K](/filings/0001551152-25-000006.md) | 2.06 Material impairments | 0001551152-25-000006 |
| 2025-01-06 | 16:02 ET | [8-K](/filings/0001551152-25-000002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000002 |
| 2024-12-13 | 16:05 ET | [8-K](/filings/0001104659-24-128413.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-128413 |
| 2024-11-04 | 14:19 ET | [10-Q](/filings/0001551152-24-000040.md) | Quarterly report, period 2024-09-30 | 0001551152-24-000040 |
| 2024-10-30 | 07:43 ET | [8-K](/filings/0001551152-24-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000036 |
| 2024-10-03 | 16:07 ET | [8-K](/filings/0001551152-24-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000033 |
| 2024-09-10 | 15:30 ET | [8-K](/filings/0001104659-24-098564.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-098564 |
| 2024-08-07 | 15:00 ET | [10-Q](/filings/0001551152-24-000031.md) | Quarterly report, period 2024-06-30 | 0001551152-24-000031 |
| 2024-07-25 | 07:41 ET | [8-K](/filings/0001551152-24-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000026 |
| 2024-07-03 | 14:07 ET | [8-K](/filings/0001551152-24-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000024 |
| 2024-05-08 | 17:00 ET | [8-K/A](/filings/0001104659-24-058808.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-24-058808 |
| 2024-05-03 | 11:04 ET | [10-Q](/filings/0001551152-24-000020.md) | Quarterly report, period 2024-03-31 | 0001551152-24-000020 |

Page 1 of 6. [Older](/companies/abbv/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 07:53 ET. No prices; not investment advice.